SEC Form 4 · accession 0001214659-19-002039
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Durrant
Officer — Chief Executive Officer · Director
Period of report
Mar 8, 2019
Accepted (ET)
Mar 11, 2019 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Mar 8, 2019 | A | 75,000 | $0.665 | A | 238,583 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option Exercise (Right to Buy)F1 | $0.665 | Mar 8, 2019 | M | 75,000 | D | Mar 9, 2018 | Sep 12, 2026 | Common Stock | 75,000 | 8,434,771 | D |
Explanation of responses
- F1These stock options were granted to the executive on March 9, 2018 to preserve the incentive offered to the executive in connection with his stock option granted on September 13, 2016, after giving effect to the dilution resulting from the completion of the Company's previously reported restructuring transaction on February 27, 2018. Accordingly, the option was deemed vested as to one-half of the underlying shares as of the grant date, with the remainder vesting in six quarterly installments commencing June 13, 2018.